Arkolith/Insider Trading/ESLA/Form 4

Xu Jiandong

Chief Financial OfficerEstrella Immunopharma, Inc. (ESLA) · full profile →Form 4 · filed Apr 29, 2026
Net Buying
Open-Market Buys
$3K
Open-Market Sells
$0
Net Open-Market Flow
$3K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Buy(P)1K$1.33$1K265K
Sep 22, 2025Buy(P)1K$1.16$1K17K
Sep 11, 2025Buy(P)100$1.04$104265K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-049602) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML